Suppr超能文献

犬上皮细胞与犬皮屑过敏原的稳定性及混合兼容性

Stability and mixing compatibility of dog epithelia and dog dander allergens.

作者信息

Grier Thomas J, LeFevre Dawn M, Duncan Elizabeth A, Esch Robert E

机构信息

Research and Development Laboratory, Greer Laboratories, Inc, Lenoir, North Carolina 28645, USA.

出版信息

Ann Allergy Asthma Immunol. 2009 Nov;103(5):411-7. doi: 10.1016/S1081-1206(10)60361-4.

Abstract

BACKGROUND

Little information or data are available concerning the stability and compatibility of dog epithelia and dog dander allergens.

OBJECTIVE

To determine the immunochemical reactivities of commercial, nonstandardized dog epithelia and dog dander extracts after exposures to various temperatures or after mixing with high-protease fungal and cockroach extracts at concentrations recommended for maintenance immunotherapy (IT) injections.

METHODS

Quantitative enzyme-linked immunosorbent assay and qualitative (immunoblot) analyses were performed to compare specific compositional changes with total or individual allergen activities. Assays for dog allergens Can f 1 and Can f 3 (albumin) used specific mouse or rabbit antibodies. Multiallergen enzyme-linked immunosorbent assay inhibition and immunoblot methods were conducted using a human serum pool with high levels of IgE to dog allergens.

RESULTS

Dog allergen recoveries ranged from 22% to 134% after short exposures to moderate or extreme temperatures and from 28% to 118% after mixing with fungal or insect extracts and storage for up to 15 months at 2 degrees C to 8 degrees C. Recoveries in dog dander extracts varied up to 2.5-fold with different test methods. Immunoblots revealed partial degradation of dog albumin molecules to discrete fragments that retained antibody-binding activities. In most cases, recoveries improved at elevated glycerin concentrations.

CONCLUSIONS

Dog allergens in epithelia and dander extracts exhibited favorable temperature stabilities. Compatibilities with fungal or insect extracts may be compromised or at risk in some combinations. These data support current IT practice parameter recommendations of separating high-protease extracts from other products if possible; they also demonstrate that dog extracts possess allergen stabilities suitable for many IT formulations.

摘要

背景

关于犬上皮细胞和犬皮屑过敏原的稳定性及兼容性,现有信息或数据较少。

目的

确定市售非标准化犬上皮细胞和犬皮屑提取物在暴露于不同温度后,或与用于维持免疫疗法(IT)注射推荐浓度的高蛋白酶真菌和蟑螂提取物混合后的免疫化学反应性。

方法

进行定量酶联免疫吸附测定和定性(免疫印迹)分析,以比较特定成分变化与总过敏原或单个过敏原活性。犬过敏原Can f 1和Can f 3(白蛋白)的测定使用特异性小鼠或兔抗体。使用对犬过敏原IgE水平高的人混合血清进行多过敏原酶联免疫吸附测定抑制和免疫印迹方法。

结果

犬过敏原在短时间暴露于中度或极端温度后的回收率为22%至134%,与真菌或昆虫提取物混合并在2℃至8℃下储存长达15个月后的回收率为28%至118%。犬皮屑提取物的回收率因不同测试方法而变化高达2.5倍。免疫印迹显示犬白蛋白分子部分降解为保留抗体结合活性的离散片段。在大多数情况下,甘油浓度升高时回收率提高。

结论

上皮细胞和皮屑提取物中的犬过敏原表现出良好的温度稳定性。与真菌或昆虫提取物的兼容性在某些组合中可能会受到影响或存在风险。这些数据支持当前IT实践参数建议,即尽可能将高蛋白酶提取物与其他产品分开;它们还表明犬提取物具有适合许多IT制剂的过敏原稳定性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验